Overlapping pathways of migraine and the endocannabinoid system: Potential therapeutic targets
{{output}}
Migraine is a disabling neurovascular disorder with limited therapeutic options, especially for patients unresponsive to current treatments targeting calcitonin gene-related peptide (CGRP) signaling. The endocannabinoid system (ECS) has emerged as a promising ... ...
